Immunic Therapeutics will receive a new U.S. patent covering its experimental therapy, vidofludimus calcium, and some related molecules in people with multiple sclerosis (MS). Titled “Treatment of multiple sclerosis comprising DHODH inhibitors,” […]
The post New patent covers progressive MS drug for patients in US appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com